Concepts (179)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Arthroplasty, Replacement, Knee | 9 | 2023 | 559 | 1.220 |
Why?
|
| Cartilage, Articular | 7 | 2019 | 274 | 1.030 |
Why?
|
| Tendon Injuries | 5 | 2014 | 159 | 0.920 |
Why?
|
| Knee Injuries | 5 | 2014 | 125 | 0.860 |
Why?
|
| Rotator Cuff | 4 | 2014 | 225 | 0.830 |
Why?
|
| Arthroplasty, Replacement, Hip | 7 | 2023 | 699 | 0.760 |
Why?
|
| Tissue Engineering | 2 | 2012 | 24 | 0.750 |
Why?
|
| Platelet-Rich Plasma | 6 | 2017 | 40 | 0.660 |
Why?
|
| Arthroscopy | 8 | 2019 | 735 | 0.630 |
Why?
|
| Osteoarthritis, Knee | 5 | 2021 | 299 | 0.620 |
Why?
|
| Knee Joint | 6 | 2023 | 576 | 0.580 |
Why?
|
| Transplantation, Homologous | 4 | 2014 | 194 | 0.550 |
Why?
|
| Rotator Cuff Injuries | 5 | 2014 | 236 | 0.550 |
Why?
|
| Knee Prosthesis | 1 | 2019 | 203 | 0.510 |
Why?
|
| Orthopedic Procedures | 3 | 2012 | 237 | 0.410 |
Why?
|
| Biomechanical Phenomena | 2 | 2011 | 534 | 0.400 |
Why?
|
| Arthralgia | 1 | 2013 | 108 | 0.380 |
Why?
|
| Arthritis, Infectious | 2 | 2023 | 48 | 0.370 |
Why?
|
| Stem Cell Transplantation | 1 | 2012 | 37 | 0.370 |
Why?
|
| Humans | 28 | 2023 | 23541 | 0.360 |
Why?
|
| Retrospective Studies | 10 | 2023 | 3122 | 0.360 |
Why?
|
| Prosthesis-Related Infections | 2 | 2023 | 177 | 0.320 |
Why?
|
| Quality of Life | 1 | 2013 | 565 | 0.310 |
Why?
|
| Reoperation | 4 | 2022 | 767 | 0.290 |
Why?
|
| Hyaluronic Acid | 3 | 2017 | 33 | 0.290 |
Why?
|
| Shoulder | 3 | 2015 | 142 | 0.270 |
Why?
|
| Middle Aged | 12 | 2019 | 8134 | 0.260 |
Why?
|
| Male | 14 | 2022 | 12743 | 0.260 |
Why?
|
| Female | 14 | 2022 | 13239 | 0.260 |
Why?
|
| Adult | 9 | 2019 | 7168 | 0.240 |
Why?
|
| Young Adult | 7 | 2019 | 1745 | 0.240 |
Why?
|
| Tibial Meniscus Injuries | 2 | 2014 | 47 | 0.200 |
Why?
|
| Menisci, Tibial | 2 | 2014 | 95 | 0.200 |
Why?
|
| Wound Healing | 2 | 2015 | 119 | 0.200 |
Why?
|
| Risk | 2 | 2023 | 163 | 0.200 |
Why?
|
| Urinary Retention | 1 | 2022 | 12 | 0.200 |
Why?
|
| Cholecalciferol | 1 | 2022 | 6 | 0.190 |
Why?
|
| Urinary Tract Infections | 1 | 2022 | 31 | 0.190 |
Why?
|
| Venous Thrombosis | 1 | 2023 | 40 | 0.190 |
Why?
|
| Anesthesia, Conduction | 1 | 2022 | 31 | 0.190 |
Why?
|
| Orthopedic Surgeons | 1 | 2022 | 24 | 0.190 |
Why?
|
| Injections, Intra-Articular | 5 | 2022 | 58 | 0.190 |
Why?
|
| Anesthetics, Local | 1 | 2022 | 70 | 0.190 |
Why?
|
| Polyethylene | 2 | 2019 | 95 | 0.180 |
Why?
|
| Shoulder Impingement Syndrome | 2 | 2011 | 10 | 0.180 |
Why?
|
| Surgeons | 2 | 2019 | 79 | 0.180 |
Why?
|
| Absorbable Implants | 2 | 2011 | 18 | 0.170 |
Why?
|
| Prosthesis Design | 2 | 2019 | 394 | 0.170 |
Why?
|
| Joint Diseases | 1 | 2021 | 95 | 0.160 |
Why?
|
| Pain Measurement | 3 | 2022 | 429 | 0.160 |
Why?
|
| Prosthesis Failure | 2 | 2019 | 422 | 0.160 |
Why?
|
| Fractures, Stress | 1 | 2019 | 16 | 0.150 |
Why?
|
| Perioperative Care | 1 | 2019 | 42 | 0.150 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2019 | 168 | 0.150 |
Why?
|
| Odds Ratio | 1 | 2019 | 229 | 0.150 |
Why?
|
| Aged | 6 | 2019 | 7572 | 0.140 |
Why?
|
| Reproducibility of Results | 3 | 2019 | 603 | 0.140 |
Why?
|
| Ambulatory Surgical Procedures | 1 | 2019 | 65 | 0.140 |
Why?
|
| Adolescent | 5 | 2014 | 1952 | 0.140 |
Why?
|
| Postoperative Period | 1 | 2019 | 269 | 0.140 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2012 | 908 | 0.140 |
Why?
|
| Patient Discharge | 1 | 2019 | 146 | 0.140 |
Why?
|
| Joint Instability | 2 | 2011 | 321 | 0.140 |
Why?
|
| Tibia | 1 | 2019 | 192 | 0.140 |
Why?
|
| Rupture | 2 | 2014 | 85 | 0.130 |
Why?
|
| Synovial Fluid | 1 | 2016 | 82 | 0.130 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2019 | 368 | 0.120 |
Why?
|
| Chondrogenesis | 1 | 2015 | 23 | 0.120 |
Why?
|
| Arthroplasty, Subchondral | 1 | 2015 | 17 | 0.120 |
Why?
|
| Cartilage | 2 | 2014 | 70 | 0.120 |
Why?
|
| Hip Prosthesis | 1 | 2019 | 443 | 0.110 |
Why?
|
| Achilles Tendon | 1 | 2014 | 6 | 0.110 |
Why?
|
| Acromion | 1 | 2014 | 21 | 0.110 |
Why?
|
| Bone-Patellar Tendon-Bone Grafting | 1 | 2014 | 23 | 0.110 |
Why?
|
| Quadriceps Muscle | 1 | 2014 | 27 | 0.110 |
Why?
|
| Patient Outcome Assessment | 1 | 2014 | 31 | 0.110 |
Why?
|
| Patellar Ligament | 1 | 2014 | 33 | 0.110 |
Why?
|
| Muscle Strength Dynamometer | 1 | 2013 | 12 | 0.110 |
Why?
|
| Range of Motion, Articular | 2 | 2014 | 600 | 0.100 |
Why?
|
| Synovial Membrane | 1 | 2013 | 47 | 0.100 |
Why?
|
| Muscle Strength | 1 | 2013 | 102 | 0.100 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2013 | 98 | 0.100 |
Why?
|
| Recovery of Function | 1 | 2013 | 255 | 0.100 |
Why?
|
| Artificial Cells | 1 | 2012 | 1 | 0.090 |
Why?
|
| Transplantation, Autologous | 1 | 2012 | 101 | 0.090 |
Why?
|
| Bone Morphogenetic Protein 2 | 1 | 2012 | 43 | 0.090 |
Why?
|
| Cumulative Trauma Disorders | 1 | 2011 | 14 | 0.090 |
Why?
|
| Treatment Outcome | 3 | 2016 | 3093 | 0.090 |
Why?
|
| Athletic Injuries | 1 | 2013 | 135 | 0.090 |
Why?
|
| Anterior Cruciate Ligament Injuries | 1 | 2012 | 142 | 0.090 |
Why?
|
| Anterior Cruciate Ligament Reconstruction | 1 | 2012 | 136 | 0.090 |
Why?
|
| Suture Anchors | 1 | 2011 | 66 | 0.090 |
Why?
|
| Follow-Up Studies | 4 | 2019 | 1492 | 0.080 |
Why?
|
| Sutures | 1 | 2010 | 38 | 0.080 |
Why?
|
| Tendons | 1 | 2011 | 172 | 0.080 |
Why?
|
| Suture Techniques | 1 | 2010 | 117 | 0.080 |
Why?
|
| Osteoarthritis | 1 | 2013 | 289 | 0.080 |
Why?
|
| Prospective Studies | 4 | 2016 | 1532 | 0.080 |
Why?
|
| Pain, Postoperative | 2 | 2022 | 282 | 0.080 |
Why?
|
| Shoulder Injuries | 1 | 2010 | 114 | 0.080 |
Why?
|
| Shoulder Joint | 2 | 2011 | 523 | 0.080 |
Why?
|
| Double-Blind Method | 2 | 2022 | 383 | 0.070 |
Why?
|
| Activities of Daily Living | 1 | 2011 | 429 | 0.070 |
Why?
|
| Postoperative Complications | 2 | 2023 | 837 | 0.070 |
Why?
|
| United States | 2 | 2022 | 1837 | 0.050 |
Why?
|
| Iatrogenic Disease | 1 | 2023 | 23 | 0.050 |
Why?
|
| Risk Factors | 2 | 2023 | 1997 | 0.050 |
Why?
|
| Urinary Catheters | 1 | 2022 | 3 | 0.050 |
Why?
|
| Urinary Catheterization | 1 | 2022 | 6 | 0.050 |
Why?
|
| Catheters | 1 | 2022 | 15 | 0.050 |
Why?
|
| Clonidine | 1 | 2022 | 17 | 0.050 |
Why?
|
| Ketorolac | 1 | 2022 | 12 | 0.050 |
Why?
|
| Time and Motion Studies | 1 | 2022 | 16 | 0.050 |
Why?
|
| Epinephrine | 1 | 2022 | 29 | 0.050 |
Why?
|
| Bupivacaine | 1 | 2022 | 39 | 0.050 |
Why?
|
| Dietary Supplements | 1 | 2022 | 55 | 0.050 |
Why?
|
| Vitamin D | 1 | 2022 | 29 | 0.050 |
Why?
|
| Morphine | 1 | 2022 | 70 | 0.050 |
Why?
|
| Anesthesia, General | 1 | 2022 | 23 | 0.050 |
Why?
|
| Arthroplasty | 1 | 2022 | 114 | 0.050 |
Why?
|
| Radiography | 2 | 2014 | 555 | 0.040 |
Why?
|
| Postural Balance | 1 | 2022 | 104 | 0.040 |
Why?
|
| Pain Management | 1 | 2022 | 132 | 0.040 |
Why?
|
| Social Class | 1 | 2021 | 55 | 0.040 |
Why?
|
| Analgesics, Opioid | 1 | 2022 | 215 | 0.040 |
Why?
|
| Pain | 1 | 2022 | 348 | 0.040 |
Why?
|
| Office Visits | 1 | 2019 | 11 | 0.040 |
Why?
|
| Time Factors | 2 | 2014 | 1293 | 0.040 |
Why?
|
| Outpatients | 1 | 2019 | 56 | 0.040 |
Why?
|
| Postoperative Care | 1 | 2019 | 114 | 0.040 |
Why?
|
| Hospitals | 1 | 2019 | 157 | 0.040 |
Why?
|
| Inpatients | 1 | 2019 | 116 | 0.040 |
Why?
|
| Lysholm Knee Score | 1 | 2016 | 4 | 0.030 |
Why?
|
| Collagen Type III | 1 | 2015 | 7 | 0.030 |
Why?
|
| Collagen Type I | 1 | 2015 | 12 | 0.030 |
Why?
|
| Tissue Scaffolds | 1 | 2015 | 20 | 0.030 |
Why?
|
| Models, Animal | 1 | 2015 | 99 | 0.030 |
Why?
|
| Rabbits | 1 | 2015 | 165 | 0.030 |
Why?
|
| X-Ray Microtomography | 1 | 2015 | 72 | 0.030 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2015 | 164 | 0.030 |
Why?
|
| Acupuncture | 1 | 2013 | 1 | 0.030 |
Why?
|
| Viscosupplementation | 1 | 2013 | 2 | 0.030 |
Why?
|
| Matrix Metalloproteinase 1 | 1 | 2013 | 5 | 0.030 |
Why?
|
| Matrix Metalloproteinase 13 | 1 | 2013 | 19 | 0.030 |
Why?
|
| Coculture Techniques | 1 | 2013 | 30 | 0.030 |
Why?
|
| Interleukin-1beta | 1 | 2013 | 38 | 0.030 |
Why?
|
| Therapeutic Irrigation | 1 | 2013 | 48 | 0.030 |
Why?
|
| Allografts | 1 | 2014 | 147 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2013 | 78 | 0.030 |
Why?
|
| Aggrecans | 1 | 2013 | 48 | 0.030 |
Why?
|
| Collagen | 1 | 2013 | 79 | 0.030 |
Why?
|
| Interleukin-6 | 1 | 2013 | 70 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2013 | 134 | 0.030 |
Why?
|
| Debridement | 1 | 2013 | 74 | 0.030 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2013 | 72 | 0.030 |
Why?
|
| Gene Expression | 1 | 2013 | 177 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2013 | 170 | 0.020 |
Why?
|
| Time-to-Treatment | 1 | 2012 | 29 | 0.020 |
Why?
|
| Observer Variation | 1 | 2012 | 88 | 0.020 |
Why?
|
| Erythrocytes | 1 | 2012 | 17 | 0.020 |
Why?
|
| Leukocytes | 1 | 2012 | 31 | 0.020 |
Why?
|
| Blood Platelets | 1 | 2012 | 35 | 0.020 |
Why?
|
| Anterior Cruciate Ligament | 1 | 2012 | 135 | 0.020 |
Why?
|
| Ceramics | 1 | 2011 | 12 | 0.020 |
Why?
|
| Benzophenones | 1 | 2011 | 21 | 0.020 |
Why?
|
| Ketones | 1 | 2011 | 19 | 0.020 |
Why?
|
| Synovitis | 1 | 2011 | 20 | 0.020 |
Why?
|
| Polymers | 1 | 2011 | 36 | 0.020 |
Why?
|
| Polyethylene Glycols | 1 | 2011 | 37 | 0.020 |
Why?
|
| Biocompatible Materials | 1 | 2011 | 71 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 3767 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2012 | 316 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2012 | 391 | 0.020 |
Why?
|
| Age Factors | 1 | 2012 | 648 | 0.020 |
Why?
|
| Osteolysis | 1 | 2011 | 113 | 0.020 |
Why?
|
| Child | 1 | 2012 | 1178 | 0.020 |
Why?
|
| Animals | 1 | 2015 | 3293 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2012 | 1465 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2010 | 1045 | 0.010 |
Why?
|